Ann: MyFiziq Signs Formal Reseller Agreement with NuraLogix, page-18

First 18 Last

Share
Profile

Follow
rocket32

1,160 Posts.

93

30/08/20

18:14

Post #: 46932756
Share

Originally posted by JAar: ↑

Mate, it's never enough hahaha.

I topped up more during the week, with each week myq is looking primed for a potential imminent SP re-rate. Details of the nuralogix deal, whilst preliminary, allow us to quantify just how extreme the revenue generation could be. It also validates that entering the health space is clearly extremely profitable for us.

If Bearn exhibits a conversion of at least 0.5-1% on the initial release, the revenue generation should be a fantastic cash buffer for myq.

I've been contemplating what Vlado and co are planning to do with the cash raised in the upcoming Nasdaq raise?
They should already have a healthy positive cashflow with Bearn and Evolt in full release by then (with high likelihood for bodixtrax and other integrations going live by then too).

Only thing I can think of is to fund a larger team to speed up future integrations? I'd be happy with that.
Having watched every development over the past 2 years, I wouldn't be suprised if Vlado is visualising something even bigger, he is an extemely ambitious man (I've always thought a hungry CEO with skin in the game is the best type of CEO).

Did anyone notice in Vlados last interview posted on HC he had mentioned WeChat being our biggest partnership with 1.2bn active users in China? We've always known that, but It's great to hear that this is still on the forefront of his mind.

I also love how Amazon's halo validates the market need for this type of solution, we are potentially years ahead of the competition with our data and deals lined up.
Alisa it's good to see you again!

Expand

myq starting to get into a good position for entry into the nasdaq

MYQ Price at posting: 40.0¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

There are more pages in this discussion • 3 more messages in this thread...

First 18 Last

Add AHI (ASX) to my watchlist

(20min delay)
Last 9.2¢		Change 0.000(0.00%)		Mkt cap ! $24.77M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Ann: MyFiziq Signs Formal Reseller Agreement with NuraLogix, page-18

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Featured News

Ann: MyFiziq Signs Formal Reseller Agreement with NuraLogix, page-18

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Featured News

Featured News